with advanced non-small cell lung cancer (NSCLC). In this study, we compared the response rate (RR), overall survival (OS), and toxicity of the combined chemotherapy regimen of liposomal paclitaxel plus cisplatin (LP) with those of TP as rst-line treatments for advanced NSCLC. Methods A total of 100 patients were randomly selected to be treated with liposomal paclitaxel or paclitaxel at a dose of 150 mg/m 2 on day 1 plus cisplatin at a dose of 75 mg/m 2 on days 1 and 2 per cycle every 21 days. Results All 100 patients were eligible. e median progression free survival was 5.1 months vs 4.2 months, the median OS was 9.0 months vs 9.3 months, and RR was 26% vs 24% in the LP and TP arms, respectively. No signi cant di erence was observed (P=0.110, 0.342 and 0.890, respectively). ere was no signi cant di erence between grades 3 and 4 toxicity of the arms (P>0.05). Peripheral neuritis observed in the LP arm was signi cantly lower than that in the TP arm (8% vs 28%), and the di erence was statistically signi cant (P=0.030). Conclusion e e ects of LP and TP as rst-line therapies for NSCLC are similar. However, peripheral neuritis in the LP arm is signi cantly lower than in the TP arm.
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单药有效率达到21%-24%，与顺铂联合有效率可达到

42%
[ （P<0.05），这也与之前国内多数报道结果相符 [7] [8] [9] [10] [11] 。分 析原因可能为紫杉醇脂质体在体内的药代动力学发生改 变，导致不良反应发生率降低 [6] 
